Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Parallel universes? An EU Commissioner has a meeting of minds with an antibiotech agitator

Article Abstract:

The European Union's Environment Commissioner Stavros Dimas and long-time biotech critic Jeremy Rifkin of the Foundation on Economic Trends are proposing a new plant breeding technology called marker-assisted selection (MAS) technology in 2006. MAS is the use of genetic markers that segregate with valuable agronomic traits to rapidly identify crossbred seedlings that contain a specific trait of interest.

Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2006
Editorial, Environmental aspects, Beliefs, opinions and attitudes, European Union, Genetically modified organisms, Rifkin, Jeremy, Dimas, Stavros

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Inhaled insulin products puff along

Article Abstract:

According to the data of European Associations for Study of Diabetes', Nektar's inhaled insulin product and other inhaled protein products will win the approval and be in the market. Nektar's dry powder formulation of inhaled insulin would provide a convenient and less painful dose and represents a potential $4.6 billion worldwide market.

Author: Powell, Kendall
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
Marketing procedures, Product introduction, Research Findings, New Products/Services, Europe, Diabetes, Diabetes mellitus, Dosage and administration, Marketing research, Insulin pumps, Market research

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


John Maraganore

Article Abstract:

John Maraganore, the CEO of Alnylam, speaks about the contribution of scientific research in the success of the company. He feels that the company's focus on the development of drugs based on RNA interference with the co-operation of its academic collaborators and industry partners has resulted in a quick progress.

Author: Huggett, Brady
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
Pharmaceutical preparations, United States, Pharmaceutical industry, Interview, Alnylam Pharmaceuticals Inc., Maraganore, John

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Officials and employees
Similar abstracts:
  • Abstracts: In vivo veritas. In vivo cancer targeting and imaging with semiconductor quantum dots. Human antibodies from immunized donors are protective against anthrax toxin in vivo
  • Abstracts: Changes in coordination, control and outcome as a result of extended practice on a novel motor skill
  • Abstracts: Protozoan genomics for drug discovery. An integrates approach to prognosis using protein microarrays and nonparametric methods
  • Abstracts: Perceptions of messages conveyed by review and audit reports. Is older goodwill value relevant?
  • Abstracts: Photographs and accountability: cracking the codes of an NGO. EGL, Inc. (EAGL)
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.